<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tessella &#187; medical</title>
	<atom:link href="http://www.tessella.com/tag/medical/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tessella.com</link>
	<description>Contact our offices: UK &#124; Netherlands &#124; USA</description>
	<lastBuildDate>Wed, 21 Jul 2010 15:20:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Bio-IT World: Separating Fact from Fiction</title>
		<link>http://www.tessella.com/2008/04/bio-it-world-separating-fact-from-fiction/</link>
		<comments>http://www.tessella.com/2008/04/bio-it-world-separating-fact-from-fiction/#comments</comments>
		<pubDate>Wed, 23 Apr 2008 14:02:15 +0000</pubDate>
		<dc:creator>teac</dc:creator>
				<category><![CDATA[Coverage]]></category>
		<category><![CDATA[drug-development]]></category>
		<category><![CDATA[medical]]></category>

		<guid isPermaLink="false">http://www.tessella.com/?p=588</guid>
		<description><![CDATA[For sponsoring companies, adaptively designed studies are not an easy segue from the traditional drug development approach where data analysis and decision-making happen on the back end of a clinical trial..read more]]></description>
			<content:encoded><![CDATA[<p>For sponsoring companies, adaptively designed studies are not an easy segue from the traditional drug development approach where data analysis and decision-making happen on the back end of a clinical trial..<a href="http://www.bio-itworld.com/ecliniqua/2008/04/23/adapting-to-adaptive-clinical-trials.html">read more</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.tessella.com/2008/04/bio-it-world-separating-fact-from-fiction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Haemophilia Home Delivery Monitoring System wins award</title>
		<link>http://www.tessella.com/2007/11/haemophilia-home-delivery-monitoring-system-wins-award/</link>
		<comments>http://www.tessella.com/2007/11/haemophilia-home-delivery-monitoring-system-wins-award/#comments</comments>
		<pubDate>Fri, 30 Nov 2007 08:08:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News & Events]]></category>
		<category><![CDATA[medical]]></category>

		<guid isPermaLink="false">http://www.tessella.com/?p=283</guid>
		<description><![CDATA[At the London NHS Innovator Awards 2007, the Haemophilia Home Delivery Monitoring System (HDMS) system was voted ICT and Software category winner. The system is the result of a close collaboration between Guy’s and St Thomas’ NHS Foundation Trust, the home delivery companies responsible for distributing the medication, Tessella and O2. Emergency interventions in Haemophilia [...]]]></description>
			<content:encoded><![CDATA[<p class="body">At the <a href="http://www.nhsinnovationslondon.com/about-us/nhs-innovator-london-competition-and-awards-2008/" target="_blank">London NHS Innovator Awards 2007</a>, the <span class="bodylink">Haemophilia Home Delivery Monitoring System</span> (HDMS) system was voted ICT and Software category winner.</p>
<p class="body">The system is the result of a close collaboration between Guy’s and St Thomas’ NHS Foundation Trust, the home delivery companies responsible for distributing the medication, Tessella and O2.</p>
<p class="body">Emergency interventions in Haemophilia are costly and can cause considerable patient harm. HDMS allows the Haemophilia Centre to:</p>
<ul class="body">
<li>Monitor blood product stock levels located at patients’ homes and at delivery companies, ensuring batch use-by-dates are complied with</li>
<li>Receive from patients their self-treatment and bleeding reports, to identify problems early before they become critical</li>
<li>Communicate with the home delivery company to schedule deliveries and if necessary to recall batches</li>
<li>Ensure patients are administering to prescription</li>
</ul>
<p class="body">The system has been working for 18 months and has attracted considerable interest from other Haemophilia centres</p>
<p class="body">Congratulations to the development team &#8211; including the Tessella consultants Simon Moss and Chris Mare (led by Rob Walker).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.tessella.com/2007/11/haemophilia-home-delivery-monitoring-system-wins-award/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
